Chemoinformaics analysis of 23-HYDROXYPHYSALOLACTONE
Molecular Weight | 555.064 | nRot | 2 |
Heavy Atom Molecular Weight | 515.752 | nRig | 30 |
Exact Molecular Weight | 554.228 | nRing | 5 |
Solubility: LogS | -2.892 | nHRing | 1 |
Solubility: LogP | 1.552 | No. of Aliphatic Rings | 5 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 77 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 38 | No. of Aromatic Carbocycles | 0 |
nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 3 |
No. of Hydrogen atom | 39 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 28 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 9 | No. of Arom Bond | 0 |
nHA | 9 | APOL | 82.1629 |
nHD | 6 | BPOL | 43.1071 |
QED | 0.293 |
Synth | 5.838 |
Natural Product Likeliness | 2.298 |
NR-PPAR-gamma | 0.018 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.132 |
Pgp-sub | 0.052 |
HIA | 0.071 |
CACO-2 | -5.259 |
MDCK | 0.0000149 |
BBB | 1 |
PPB | 0.620217 |
VDSS | 0.71 |
FU | 0.388883 |
CYP1A2-inh | 0.003 |
CYP1A2-sub | 0.958 |
CYP2c19-inh | 0.015 |
CYP2c19-sub | 0.821 |
CYP2c9-inh | 0.008 |
CYP2c9-sub | 0.056 |
CYP2d6-inh | 0.001 |
CYP2d6-sub | 0.079 |
CYP3a4-inh | 0.327 |
CYP3a4-sub | 0.931 |
CL | 3.156 |
T12 | 0.129 |
hERG | 0.025 |
Ames | 0.019 |
ROA | 0.997 |
SkinSen | 0.015 |
Carcinogencity | 0.31 |
EI | 0.007 |
Respiratory | 0.577 |
NR-Aromatase | 0.95 |
Antiviral | Yes |
Prediction | 0.812925 |